BIRC6 and prostate cancer: With increasing evidence that autophagy may serve as a survival mechanism of cells in response to stress, including anti-cancer therapeutics [7], BIRC6 may be a suitable target for inhibition of autophagy-mediated cell survival and for treatment resistance in prostate cancer cells.